Savaria (TSE:SIS – Get Free Report) had its price target upped by Raymond James Financial from C$27.00 to C$32.00 in a research note issued on Friday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Raymond James Financial’s price target indicates a potential upside of 23.31% from the company’s current price.
A number of other research analysts also recently issued reports on SIS. TD Securities boosted their price target on Savaria from C$27.00 to C$31.00 and gave the company a “buy” rating in a report on Thursday. Stifel Nicolaus boosted their target price on shares of Savaria from C$28.00 to C$29.00 and gave the company a “buy” rating in a research note on Friday. Desjardins raised their price target on shares of Savaria from C$27.00 to C$32.00 and gave the company a “buy” rating in a research report on Friday. National Bank Financial lifted their price objective on shares of Savaria from C$30.00 to C$30.50 and gave the company an “outperform” rating in a report on Friday. Finally, Scotiabank increased their target price on shares of Savaria from C$25.00 to C$26.00 in a research note on Monday, November 10th. Seven research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of C$30.93.
Read Our Latest Stock Report on SIS
Savaria Stock Performance
Savaria (TSE:SIS – Get Free Report) last issued its quarterly earnings data on Wednesday, March 4th. The company reported C$0.37 earnings per share (EPS) for the quarter. Savaria had a return on equity of 10.24% and a net margin of 6.90%.The business had revenue of C$241.78 million during the quarter. Analysts anticipate that Savaria will post 1.2048518 EPS for the current fiscal year.
About Savaria
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Stories
- Five stocks we like better than Savaria
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
